Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2002 Jan;82(1):33-9.
doi: 10.1016/s0167-5273(01)00578-2.

Characterization of myocardial hypertrophy by DNA content, PCNA expression and apoptotic index

Affiliations

Characterization of myocardial hypertrophy by DNA content, PCNA expression and apoptotic index

Luigi Matturri et al. Int J Cardiol. 2002 Jan.

Abstract

Background: At present little is known about the biological basis of cellular alterations in myocardial hypertrophy. The present study aims to analyze proliferating cell nuclear antigen (PCNA) expression, DNA content and apoptosis, in several types of myocardial hypertrophy in order to define the biological characteristics of this process.

Methods: The biological parameters were investigated in normal hearts (n=4) and in 21 cases of left ventricular myocardial hypertrophy related to pressure overload (n=7), post-infarction remodeling (n=8) and hypertrophic cardiomyopathy (HCM) (n=8).

Results: The analyzed biomarkers were similar in hypertension and in remodeling, with a very high apoptotic index (mean values: 8.1 and 8.5%, respectively), a low PCNA positivity (mean values: 1.8 and 1.6%) and a prevalent diploid DNA content (DNA index: 1.2). Conversely, HCM showed a high mean PCNA index (21.2%) associated with a prevalence of hyperdiploid myocytes (DNA index: 1.8) and a low number of apoptotic cells (mean value: 1.7%).

Conclusions: There are significant biological differences between hypertrophy in HCM and that related to arterial hypertension and post-infarction remodeling. Therefore, the combined evaluation of DNA content, PCNA and apoptotic indices could provide a powerful diagnostic tool in doubtful cases of myocardial primary or secondary hypertrophy and open new avenues in the clinical treatment of these entities.

PubMed Disclaimer

Similar articles

Cited by

LinkOut - more resources